Open Access

EDITORIAL

Thomas W. Jarrett
Canadian Journal of Urology, Vol.17, No.4, pp. 5245-5245, 2010
Abstract This article has no abstract. More >

View

46

Download

33

Open Access

BOOK REVIEW

Rosenblatt, Alberto, Campos Guidi, Homero Gustavo de
Canadian Journal of Urology, Vol.17, No.4, pp. 5246-5246, 2010
Abstract This article has no abstract. More >

View

47

Download

35

Open Access

LEGENDS IN UROLOGY

Richard D. Williams
Canadian Journal of Urology, Vol.17, No.4, pp. 5247-5248, 2010
Abstract This article has no abstract. More >

View

32

Download

34

Open Access

REVIEW

Bob Djavan¹, Elisabeth Eckersberger¹, Markus Johannes Handl², Roland Brandner¹, Helen Sadri¹, Herbert Lepor¹
Canadian Journal of Urology, Vol.17, No.4, pp. 5249-5254, 2010
Abstract Background: Transurethral resection of the prostate (TURP) has been the gold standard of the treatment of benign prostatic hyperplasia (BPH). In recent years there has been a significant shift in the treatment of BPH and guidelines emphasize minimally invasive surgery as a new treatment option. Minimal invasive technologies (MITs), such as transurethral microwave thermotherapy (TUMT), laser ablations, transurethral needle ablation (TUNA) have emerged as an alternative to the TURP.
Objectives: To assess the retreatment rates of the most commonly used minimal invasive techniques.
Search strategy: Durability articles were selected by using defined search terms using PubMed as search engine.
… More >

View

43

Download

35

Open Access

ARTICLE

Chukwudi O. Okorie¹, Louis L. Pisters²
Canadian Journal of Urology, Vol.17, No.4, pp. 5255-5258, 2010
Abstract Objectives: Hemostasis during suprapubic prostatectomy for benign prostatic hyperplasia (BPH) is commonly affected by placing sutures at the 5 o'clock position and the 7 o'clock position of the bladder neck. However, the urethral arterial branches of the inferior vesical artery that supplies the prostate extend from the 1 o'clock to 5 o'clock position and from the 7 o'clock to 11 o'clock position of the bladder neck, with the largest branches located posteriorly. This study analyses the effect of a modified suprapubic prostatectomy technique, which covered the area from the 1 o'clock position to the 11 o'clock… More >

View

39

Download

33

Open Access

ARTICLE

Daniel Taussky¹, Guila Delouya¹, Fabio Lefebvre¹, Aihua Liu², Michal Abrahamowicz², Jean-Paul Bahary¹, David Donath¹
Canadian Journal of Urology, Vol.17, No.4, pp. 5259-5264, 2010
Abstract Purpose: Among men who underwent permanent seed prostate brachytherapy, we aimed to: 1) investigate whether development of lower urinary tract symptoms (LUTS) after permanent seed prostate brachytherapy was associated with suboptimal erectile function before brachytherapy, and 2) identify factors that are associated with normal erectile function before brachytherapy.
Methods and materials: We analyzed data from 215 consecutive patients with low-or intermediate-risk prostate cancer who received permanent seed brachytherapy at our center. Erectile function at baseline (prior to brachytherapy) was assessed using the Mount Sinai Erectile Function Score (MSEFS). Urinary symptoms at baseline and at 1 month and… More >

View

49

Download

34

Open Access

ARTICLE

Bob Djavan¹, Peter Schlegel², Georg Salomon³, Elisabeth Eckersberger¹, Helen Sadri¹, Markus Graefen³
Canadian Journal of Urology, Vol.17, No.4, pp. 5265-5271, 2010
Abstract Background: Androgen deprivation therapy (ADT) is the standard care in men with advanced prostate cancer. Continuous testosterone suppression is essential to treatment efficacy. Recently a 1 year depot compound histrelin, (VANTAS; Orion Pharmaceuticals, Finland; Endo Pharmaceuticals, USA), a gonadotropin-releasing hormone (GnRH) analog, was approved for hormone therapy of prostate cancer. In the present study the therapeutic efficacy of this compound was investigated, in addition to its impact on testosterone values and velocity as well as PSA.
Method: One hundred thirty-one patients with histologically confirmed prostate cancer and normal testosterone levels were prospectively evaluated over 1 year. Androgen… More >

View

53

Download

40

Open Access

ARTICLE

Rena Malik, Juliana Laze, Herbert Lepor
Canadian Journal of Urology, Vol.17, No.4, pp. 5272-5277, 2010
Abstract Objective: To evaluate the efficacy of local compression and topical epinephrine in controlling perioperative bleeding during open radical retropubic prostatectomy (ORRP) and its impact on the degree of urinary extravasation on initial postoperative cystogram.
Methods: Between September 2005 to March 2009, 476 men underwent ORRP performed by a single surgeon. Group 1 (n = 200) underwent ORRP between September 2005 and November 2006 without pelvic compression; Group 2 (n = 76) underwent ORRP between November 2006 and May 2007 and a dry laparotomy pad was positioned in the pelvis immediately prior to abdominal wound closure; Group 3… More >

View

52

Download

35

Open Access

ARTICLE

Deborah J. Lightner, Bryan C. Bruner
Canadian Journal of Urology, Vol.17, No.4, pp. 5278-5282, 2010
Abstract Introduction/objectives: Our objective was to review our experience with lower urinary tract leiomyomata to determine if presentation, exam and imaging allows for stratification of the treatment of this rare lesion.
Materials and methods: A retrospective review of current practice was performed from the Mayo Clinic Rochester database identifying 13 female patients and 10 males from 1995-2008, focusing on the clinical presentation, cystoscopic findings, imaging and operative approaches.
Results: Symptomatic patients had larger lesions, were more likely to be females, or had midline periurethral or bladder neck lesions. Cystoscopic findings were uniformly described as submucosal polypoid lesions without surrounding… More >

View

35

Download

34

Open Access

ARTICLE

Jean F. Wyman¹, Carl Klutke², Kathryn Burgio³, Zhonghong Guan⁴, Franklin Sun⁴, Sandra Berriman⁴, Tamara Bavendam⁴
Canadian Journal of Urology, Vol.17, No.4, pp. 5283-5290, 2010
Abstract Objective: To assess the effects of tolterodine extended release (ER) plus behavioral intervention on urgency and other patient-reported outcomes in subjects with overactive bladder (OAB) who were previously dissatisfied with antimuscarinic treatment.
Methods: In this 16-week, multicenter, open-label study, eligible adults (aged ≥ 18 y) reported dissatisfaction with their most recent antimuscarinic OAB medication; ≥ 8 micturitions and ≥ 2 urgency episodes per 24 hours and ≥ 1 UUI episode in 5 day bladder diaries; and OAB symptoms for ≥ 3 months. Subjects received tolterodine ER plus a behavioral educational handout with verbal reinforcement of behavioral intervention… More >

View

50

Download

31

Open Access

MINIMALLY INVASIVE AND ROBOTIC SURGERY

Daniel J. Moskovic, Hugh J. Lavery, Jamil Rehman, Fatima Nabizada-Pace, Jonathan Brajtbord, David B. Samadi
Canadian Journal of Urology, Vol.17, No.4, pp. 5291-5298, 2010
Abstract Introduction: Given the anatomic constraints of obese patients, concern exists as to whether robotic assisted laparoscopic prostatectomy (RALP) is appropriate in patients with higher body mass index (BMI). We reviewed a large RALP database to determine if clinical outcomes are related to BMI.
Methods: The records of patients who underwent a RALP from 2003-2009 were reviewed. BMI stratifications were concordant with the Centers for Disease Control (CDC) standards: ≥ 30, ≥ 25 and < 30, and < 25 were classified as obese, overweight, and normal weight, respectively. Baseline, perioperative, histopathologic, and functional outcome data were collected.
Results: A… More >

View

39

Download

43

Open Access

MINIMALLY INVASIVE AND ROBOTIC SURGERY

Ashok K. Hemal¹, Rishi Nayyar², Narmada P. Gupta², Lalgudi N. Dorairajan¹
Canadian Journal of Urology, Vol.17, No.4, pp. 5299-5305, 2010
Abstract Objective: Early results indicate that robot assisted laparoscopic surgery (RALS) may be useful in managing upper tract (UT) urolithiasis. We reviewed our experience of managing 50 cases of UT urolithiasis with or without reconstruction using RALS.
Materials and methods: We performed a record review of 50 cases of RALS for UT urolithiasis performed in two institutions from July 2006 to June 2009. The RALS procedures included pyeloplasty with pyelolithotomy (29 cases), ureterolithotomy, tailoring and reimplantation for megaureters (5 cases), ureterolithotomy with ureteral stricture reconstruction (1 case), primary UT stone surgeries (8 cases), partial nephrectomy (1 case) and… More >

View

43

Download

31

Open Access

CASE REPORT

Eman R. Boulis, Vikas Majithia
Canadian Journal of Urology, Vol.17, No.4, pp. 5306-5308, 2010
Abstract Testicular involvement in connective tissue diseases (CTD) is typically caused by medium vessel vasculitis as in polyarteritis nodosa. Systemic lupus erythrematosus (SLE) and systemic sclerosis cause small vessel vasculitis, which is an unusual cause of orchitis. We hereby report a case of orchitis in a 28-year-old patient caused by vasculitis related to his lupus/scleroderma overlap CTD. He had an excellent response to steroids and azathioprine with complete resolution of his testicular and systemic symptoms. Our case highlights that although testicular involvement secondary to small vessel vasculitis in CTD is uncommon, it is still possible and More >

View

42

Download

32

Open Access

RESIDENT’S CORNER

Zachary Piotrowski¹, Daniel J. Canter², Alexander Kutikov², Tahseen Al-Saleem^3,4, Jianming Pei⁵, Joseph R. Testa^4,6, Robert G. Uzzo²
Canadian Journal of Urology, Vol.17, No.4, pp. 5309-5312, 2010
Abstract Purpose: A case of the rare, benign, Wilms’ tumor (WT) variant, metanephric adenofibroma (MAF), is presented.
Materials and methods: The patient is a 21-year-old female with an incidentally discovered enhancing renal mass. The diagnosis, workup and treatment are outlined.
Results: The 19 cm renal mass was ultimately resected via robot-assisted partial nephrectomy. Pathologic diagnosis at our institution was confirmed as a MAF by the National Wilms’ Tumor Study Group (NWTSG).
Conclusion: Difficult to differentiate from WT, it is imperative that MAF be recognized and appropriately diagnosed because unlike adult WT, the natural history of MAF is indolent and adjuvant More >

View

53

Download

36

Open Access

ABSTRACT

Canadian Journal of Urology, Vol.17, No.4, pp. 5313-5333, 2010
Abstract This article has no abstract. More >

View

37

Download

33

Open Access

CLINICAL TRIALS

Richard W. Casey¹, Jack Barkin²
Canadian Journal of Urology, Vol.17, No.4, pp. 5334-5337, 2010
Abstract This article has no abstract. More >

View

38

Download

32

Open Access

CLINICAL TRIALS

Eric Winquist, George Rodrigues
Canadian Journal of Urology, Vol.17, No.4, pp. 5338-5342, 2010
Abstract This article has no abstract. More >

View

43

Download

36